Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.

Bacteria-Based Test Strips Can Monitor Blood Glucose

By Labmedica International staff writers
Posted on 26 Jan 2012
Segments of DNA embedded in bacteria can be coded to detect changes in osmolarity resulting from the presence of glucose in a blood sample.

Students at the Missouri University of Science and Technology (MST, Rolla, USA) used a nonvirulent strain of E.coli with designed genes integrated in the bacteria’s DNA, enabling them to sense the presence of glucose in correlation to changes in osmolarity. When glucose is detected, the bacteria emit a yellow glow, and as its concentration rises, so does the light emitted glow brighter. The system might also eventually serve as the basis for a new method to monitor blood glucose levels by replacing the fluorescent gene with one that would make the bacteria change color, based on glucose concentrations.

To make the device, the students used an intermediate biobrick with a ribosome-binding site and the reporter gene (eYFP), which was then coupled to another biobrick that had three binding sites for the transcriptional regulatory protein phosphorylated OmpR. The phosphorlyation of OmpR by EnvZ (an inner membrane protein that senses osmolarity) positively correlated with the osmolarity of the system. When one or two of the binding sites are occupied, RNA polymerase is recruited to begin downstream transcription of eYFP. However, when all three OmpR binding sites are occupied, RNA polymerase cannot bind, the reporter gene can no longer be produced, and the system is inhibited.

As osmolarity increases from very low levels, the fluorescence produced by the system increases, until it reaches a threshold osmolarity level that when crossed causes the fluorescence to decrease as a result of the ensuing inherent down-regulation of the system. The activity of the system can be quantified because the two-component regulatory system of EnvZ and OmpR controls transcription of the eYFP gene, dictating the level of fluorescence.

“All you would have to do is put the DNA inside a bacteria and you've got your test strip,” said Erica Shannon, a senior year student in biological sciences at MST. “In the future, based on further research, an insulin gene could be added to this system for use in insulin pumps, where specific glucose levels trigger insulin production.”

The project was developed the system as part of an annual competition sponsored by the International Genetically Engineered Machine Foundation (iGEM; Boston, MA, USA) held during October 2011, in Indianapolis (IN, USA); the MST iGEM chapter received a silver medal for their effort.

Related Links:

Missouri University of Science and Technology
International Genetically Engineered Machine Foundation




PURITAN MEDICAL
EUROIMMUN AG
Sekisui Diagnostics
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel
Image: Enzyme-linked immunosorbent kit (ELISA) specific for human copeptin (Photo courtesy of USCN Life Science).

Preeclampsia Biomarker Detected Very Early In Pregnancy

A biomarker has been discovered that could give expecting mothers and their doctors the first simple blood test to reliably predict that a pregnant woman may develop preeclampsia, at least as early as... Read more

Pathology

view channel
Image: Glioblastoma multiforme (GBM) (Photo courtesy of the University of California, San Diego School of Medicine).

Brain Tumor Chemotherapy Biomarkers Identified

Cancer researchers have identified a new biomarker that they believe can predict whether glioblastoma multiformes (GBMs), the most common and aggressive type of malignant brain tumor, will be susceptible... Read more

Lab Tech.

view channel
Image: The ADVIA Centaur XPT Immunoassay System delivers the results that clinicians depend upon for accurate diagnoses and better patient care (Photo courtesy of Siemens Healthcare).

Introduction of New Central Laboratory Clinical Analyzers Highlights Recent Lab Equipment Exposition

An impressive array of new automated analyzers for central diagnostic laboratories was unveiled at a recent lab equipment trade fair. The IFCC WorldLab exposition held June 22-26, 2014, in Istanbul... Read more

Industry News

view channel

EKF Wins Distribution Contract and Regulatory Approval for Target Regions

EKF Diagnostics Holdings (Cardiff, Wales, UK), an AIM-listed point-of-care, central laboratory and molecular diagnostics business, announced that it has signed a new distribution contract in China and that one of its OEM (original equipment manufacturer) partners has received further regulatory approval across several target... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.